Which vein is indicated by the X in the picture below?

Fill in the blank

dropdown

A. major histocompatibility complex: MHC (human leukocyte antigen, HLA) matching is critical because disparities trigger strong T-cell–mediated rejection responses.
B. antibody response: the recipient’s antibody response intensity matters clinically, but you don’t “match” antibody responses between donor and recipient; rather you try to match MHC and blood type.
C. blood type: blood type mismatches can cause hyperacute rejection and are important to consider, but MHC/HLA matching is the key determinant of long-term rejection risk.
D. sex and age: sex and age are not major determinants of graft compatibility; they are not the primary matching criteria used to reduce rejection risk.

A. Altered oxygen-carrying capability of blood: RBCs (via hemoglobin) are the primary carriers of oxygen; too few (anemia) or dysfunctional RBCs reduce O₂ delivery, too many (polycythemia) can alter flow.
B. Altered ability to clot blood: clotting is primarily mediated by platelets and clotting factors, not by RBC count (RBCs can influence viscosity but are not the main clotting elements).
C. Altered ability to fight infection: fighting infection is mainly the role of leukocytes (WBCs), not RBCs.
D. Altered heart rate and contractility: significant changes in RBC number (especially anemia) can cause compensatory increases in heart rate and contractility to maintain oxygen delivery; polycythemia can also change cardiac workload.